CJC-1295 vs Ipamorelin

Overview

CJC-1295 and ipamorelin work through different mechanisms to stimulate growth hormone release. CJC-1295 is a GHRH analog that acts on the GHRH receptor, while ipamorelin is a GHRP that acts on the ghrelin receptor. They are frequently combined in research due to their complementary mechanisms. Neither is FDA-approved.

Key Facts

Aspect	CJC-1295	Ipamorelin
Class	GHRH analog	GHRP
Structure	30 amino acids	5 amino acids
Target Receptor	GHRH-R	GHS-R1a
FDA Status	Not approved	Not approved
Variants	DAC and non-DAC	Single form

Mechanism Comparison

Aspect	CJC-1295	Ipamorelin
Receptor Type	GHRH receptor	Ghrelin receptor
Natural Analog	GHRH	Ghrelin mimetic
GH Synthesis	Stimulates	Does not stimulate
GH Release	Yes	Yes
Half-life	30 min (no DAC) or 6-8 days (DAC)	~2 hours

Different Receptor Pathways

CJC-1295 (GHRH pathway):

• Binds GHRH receptor on pituitary
• Stimulates both GH synthesis and release
• Works like natural GHRH
• Maintains physiological pulsatility

Ipamorelin (Ghrelin pathway):

• Binds ghrelin receptor (GHS-R1a)
• Amplifies GH release signal
• Complements GHRH signaling
• Selective for GH (minimal cortisol/prolactin)

CJC-1295 Variants

Variant	Description	Half-life
CJC-1295 no DAC	Modified GHRH 1-29	~30 minutes
CJC-1295 DAC	With Drug Affinity Complex	6-8 days
Mod GRF 1-29	Same as CJC-1295 no DAC	~30 minutes

Important: CJC-1295 DAC creates sustained GH elevation (not pulsatile), which may not be physiological.

Evidence Comparison

Aspect	CJC-1295	Ipamorelin
Human Studies	Limited (Phase 2)	Limited (Phase 2)
Combination Studies	Some	Some
Development Status	Abandoned	Abandoned
Publication Quality	Low-moderate	Low-moderate

GH Release Patterns

Parameter	CJC-1295 no DAC	CJC-1295 DAC	Ipamorelin
GH Peak	2-3x baseline	Sustained elevation	2-4x baseline
Duration	~3 hours	Days	~3 hours
Pattern	Pulsatile	Continuous	Pulsatile
Physiological	More	Less	Yes

Side Effect Profile

CJC-1295 (No DAC)

Effect	Likelihood	Notes
Flushing	Common	After injection
Headache	Occasional	Usually mild
Water retention	Possible	GH-related
Injection site	Common	Typical for peptides

CJC-1295 DAC

Effect	Likelihood	Notes
Sustained GH elevation	Expected	May not be ideal
Water retention	More likely	Due to sustained GH
IGF-1 increase	Prolonged	Continuous effect

Ipamorelin

Effect	Likelihood	Notes
Cortisol elevation	Minimal	Key advantage
Prolactin elevation	Minimal	Key advantage
Appetite increase	Minimal	Unlike other GHRPs
Headache	Occasional	Usually transient

Combination Rationale

CJC-1295 and ipamorelin are frequently combined:

Mechanism	CJC-1295	Ipamorelin	Combined
GHRH receptor	Agonist	None	Stimulated
Ghrelin receptor	None	Agonist	Stimulated
GH release	++	++	+++ to ++++
Synergy	-	-	Potential

Why Combine?

1. Different receptors - No competition
2. Complementary signaling - GHRH sets up, ghrelin amplifies
3. Potentially greater GH pulse - Synergistic effect
4. Maintained selectivity - Ipamorelin keeps profile clean

Regulatory Status

Aspect	CJC-1295	Ipamorelin
FDA Approval	No	No
Development	Abandoned	Abandoned
Availability	Research chemical	Research chemical
WADA Status	Prohibited	Prohibited

Administration (Research Context)

Aspect	CJC-1295 no DAC	CJC-1295 DAC	Ipamorelin
Route	Subcutaneous	Subcutaneous	Subcutaneous

Key Differences

Factor	CJC-1295	Ipamorelin
Receptor	GHRH-R	GHS-R1a
Mechanism	GHRH analog	Ghrelin mimetic
GH Synthesis	Stimulates	No direct effect
Half-life	Varies (30 min to days)	~2 hours
Selectivity	High	High
Cortisol Effect	Minimal	Minimal

Summary

• CJC-1295 is a GHRH analog that stimulates GH synthesis and release via GHRH receptor
• Ipamorelin is a selective GHRP that amplifies GH release via ghrelin receptor
• Different receptors allow combination use without competition
• CJC-1295 DAC creates non-physiological sustained GH elevation
• Ipamorelin’s selectivity (minimal cortisol/prolactin) is a key advantage
• Neither is FDA-approved; both are research chemicals only

---

This comparison is for educational purposes only. Neither peptide is approved for human use. Products sold are unregulated research chemicals with uncertain quality and safety.